Expression of bcl-2 and apoptotic DNA fragmentation in human endometrial adenocarcinoma cells

Anticancer Research

Volumn 16, Issue 5 B, 1996, Pages 3221-3224

  Kuwashima, Yoshio ^a   Kobayashi, Yasuhito ^a   Kawarai, Atsuko ^a   Uehara, Toshitaka ^a   Kurosumi, Masafumi ^a   Tanuma, Junichi ^a,b   Shiromizu, Kenji ^a   Matsuzawa, Masumi ^a   Kishi, Kiyozo ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; bcl 2; DNA fragmentation; Endometrial carcinoma

Indexed keywords

DNA FRAGMENT; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DNA DEGRADATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ONCOGENE; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; DNA FRAGMENTATION; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029820997     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wylie AH, Kerr J and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
2. Kerr JFR: Definition of apoptosis and overview of its incidence. In: Programmed cell death(Lavin M and Watters D, eds). Switzerland, Harwood Academic Publishers, 1993, pp 1-15.
3. Majno G and Joris I: Apoptosis, oneosis. and necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995.
4. Hollowood K and Macartney JC: Reduced apoptotic cell death in follicular lymphoma. J Pathol 163: 337-342, 1991.
5. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098, 1991.
6. Tsujimoto Y, Cossman J, Jaffe E, and Croce CM: Involvement of the bcl-2 gene in human follicular Iymphoma. Science 228: 1440-1443, 1985.
7. Korsmeyer SJ: Bcl-2: an antidote to programmed cell death. Cancer Surv 15: 105-118, 1992.
8. Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, Decroix Y and Poitout P: Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144: 1195-1202, 1994.
9. Walker PR, Kokileva L, LeBlanc J and Sikorska M: Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques 15: 1032-1047, 1993.
10. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 443-501, 1992.
11. Kasagi N, Gomyo Y, Shirai H, Tsujitani S and Ito H: Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Jpn J Cancer Res 85: 939-945, 1994.
12. Saegusa M, Takano Y, Wakabayashi T and Okayasu I: Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. Jpn J Cancer Res 86: 743-748, 1995.
13. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex(ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody(PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
14. Hayashi Y, Hachisuga T, Iwasaka, Fukuda K, Okuma Y, Yokoyama M and Sugimori H: Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinoma and its relationship to Iymph node involvement. Gynecol Oncol 40: 147-151, 1991.
15. Gulbis B and Galand P: Immunodetection of the p21-ras products in human normal and preneoplastic tissue and solid tumors: a review. Hum Pathol 24: 1271-1285, 1993.
16. DePotter CR: The neu-protein and breast cancer. Virchows Archiv 426: 107-115, 1995.
17. Reed JC: Bcl-2 and regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
18. Hockenberg D, Nunez G, Milliam C, Schreider RD and Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990.
19. Uehara T, Kuwashima Y, Izumo T, Kishi K, Shiromizu K and Matsuzawa M: Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome. Eur J Gynaec Oncol 16: 453-460, 1995.
20. Hurlimann J, Larrinaga B and Vala DLM: Bcl-2 protein in invasive ductal breast carcinomas. Virchows Archiv 426: 163-168, 1995.
21. Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC and Reed JC: Immunohistochemical analysis of bcl-2 protein regulation in cutancous melanoma. Am J Pathol 146: 643-650, 1995.
22. Kuwashima Y, Uehara T, Kishi K, Shiromizu K, Matsuzawa M and Takayama S: Proliferative and apoptotic status in endometrial adenocarcinoma. Int J Gynecol Pathol 14: 45-49, 1995.
23. Hiraishi K, Suzuki K, Hakomori S and Adachi M: Le(y) antigen expression is correlated with apoptoHis(programmed cell death). Glycobiol 3: 381-390, 1993.